KCNQ2-related developmental and epileptic encephalopathy

KCNQ2-related developmental and epileptic encephalopathy (KCNQ2-DEE) is a rare genetic brain disorder caused by changes (mutations) in the KCNQ2 gene. This gene provides instructions for making a type of potassium channel in the brain, which helps control the electrical activity of nerve cells. When this channel does not work properly, nerve cells can become overactive, leading to seizures and problems with brain development. Babies with KCNQ2-DEE typically begin having seizures in the first days to weeks of life. These seizures are often frequent and can be difficult to control with standard medications. The condition also causes significant developmental delays, meaning children may be slow to reach milestones like sitting, crawling, walking, and talking. Many children develop intellectual disability that ranges from moderate to severe. Some children also experience movement problems, such as stiffness or abnormal muscle tone. The treatment landscape for KCNQ2-DEE focuses on controlling seizures and supporting development. Certain anti-seizure medications, particularly sodium channel blockers like carbamazepine and phenytoin, have shown better effectiveness in this condition compared to other epilepsy drugs. Early and accurate diagnosis through genetic testing is important because it can guide doctors toward the most effective treatments. Physical therapy, occupational therapy, and speech therapy are also key parts of care. Research into targeted therapies, including gene therapy and drugs that specifically act on KCNQ2 channels, is ongoing and offers hope for future treatments.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Bring these to your next appointment

• Q1.What specific KCNQ2 mutation does my child have, and what does it mean for their prognosis?,Are sodium channel blockers like carbamazepine the best treatment option for my child's specific mutation?,Are there any medications we should avoid because they could worsen my child's seizures?,What is the emergency seizure action plan, and should we have rescue medication at home?,What early intervention therapies should we start, and how often should they occur?,Are there any clinical trials or research studies my child might be eligible for?,Should other family members be tested for the KCNQ2 gene change, and what does this mean for future pregnancies?

Common questions about KCNQ2-related developmental and epileptic encephalopathy